Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Medical Ethics 2001;27:398-403; doi:10.1136/jme.27.6.398
Copyright © 2001 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.
J Med Ethics 2001; 27:398-403
© 2001 the Journal of Medical Ethics

Let the consumer decide? The regulation of commercial genetic testing

Dr Mairi Levitt

University of Central Lancashire, Preston

Abstract

Objectives—The development of predictive genetic tests provides a new area where consumers can gain knowledge of their health status and commercial opportunities. "Over-the-counter" or mail order genetic tests are most likely to provide information on carrier status or the risk of developing a multifactorial disease. The paper considers the social and ethical implications of individuals purchasing genetic tests and whether genetic information is different from other types of health information which individuals can obtain for themselves.

Design—The discussion is illustrated by findings from a questionnaire survey of university students as potential consumers. Topics covered included what health tests they had already used, expectations of genetic tests, willingness to pay, who should have access to the results and whether there need to be restrictions on such tests.

Sample—Six hundred and fifteen first-year students in the universities of Leuven, Cardiff, Central Lancashire, Vienna and Nijmegen studying either medicine or a non-science subject.

Results—Students were enthusiastic about genetic tests and had high expectations of their accuracy and usefulness but most thought they should be available through the health service and a minority thought that some tests, for example for sex selection, should not be available at all. There were few differences in responses by sex or subject of study but some by country. The paper also considers ethical and social issues outside the scope of a questionnaire survey of this type.

Conclusion—To address some of these issues the sale of genetic tests to individuals can be made subject to ethical guidelines or codes of practice, for example to protect vulnerable groups, but there are fundamental social and ethical questions which such guidelines cannot address.

Key Words: Genetic tests • European • commercialisation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Gray, S. W., O'Grady, C., Karp, L., Smith, D., Schwartz, J. S., Hornik, R. C., Armstrong, K. (2009). Risk Information Exposure and Direct-to-Consumer Genetic Testing for BRCA Mutations among Women with a Personal or Family History of Breast or Ovarian Cancer. Cancer Epidemiol. Biomarkers Prev. 18: 1303-1311 [Abstract] [Full Text]  
  • Campbell, E, Ross, L F (2004). Attitudes of healthcare professionals and parents regarding genetic testing for violent traits in childhood. J. Med. Ethics 30: 580-586 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.